DUBLIN–(BUSINESS WIRE)–The “Dystonia Drugs Market by Drug Type, Route of Administration, Distribution Channel, and Geography: Forecast up to 2027” report has been added to ResearchAndMarkets.com’s offering.
The dystonia drugs market is expected to grow at a compound annual growth rate (CAGR) of 5.3% by 2027. This growth is driven by untapped emerging markets, improving healthcare infrastructure, rising unmet healthcare needs, and the demand for advanced healthcare facilities.
The market is also benefiting from an increase in the prevalence of dystonia and other neurological disorders with dystonia symptoms, which is boosting the demand for dystonia treatment medications.
Dystonia is a movement disorder characterized by involuntary muscle contractions leading to slow, repetitive movements or abnormal postures. It can affect single muscles, groups of muscles, or the entire body.
Market Segmentation
The Dystonia Drugs Market is segmented by drug type, route of administration, distribution channel, and geography.
Drug Types:
- Anticonvulsants drugs
- Dopaminergic agents
- GABAergic agents
- Others
Among these, GABAergic agents have the largest market share, attributed to their effectiveness in treating dystonia, especially cervical dystonia. The pharmaceutical industry’s discovery of highly effective GABAergic agent medications for dystonia treatment is further driving the growth of this segment.
Route of Administration:
- Oral
- Injectable
The injectable segment holds a significant market share due to innovations in parenteral dosing and increased research and development for botulinum injections. Injectable medications are rapidly absorbed, resulting in a swift onset of effects compared to oral and subcutaneous methods.
Distribution Channel:
- Hospital Pharmacies
- Online Providers
- Drug Stores and Retail Pharmacies
The drug stores and retail pharmacies segment dominates the market, benefiting from its extensive distribution network and longstanding presence as a convenient channel for drug distribution. Retail pharmacists play a crucial role in preparing and dispensing drugs, advising consumers on proper medication usage, and educating them about potential drug interactions.
Geographic Analysis:
- North America
- Europe
- Asia Pacific
- Rest of the World
North America holds a substantial market share due to the increasing incidence of dystonia and related neurological conditions in the United States and other major countries. Government influence on private research and development investments and policies related to drug supply and demand contribute to market growth. The pharmaceutical industry’s global research and development efforts are expected to enhance the effectiveness of dystonia drugs, further driving market growth.
Key Vendors:
- Teva Pharmaceuticals Industries Ltd.
- F. Hoffmann-La Roche Ltd.
- Merz Pharma GmbH & Co. KGaA
- Ipsen Pharma Biotech SAS
- Hameln Pharma Gmbh (Siegfried Group, LLP)
- AbbVie, Inc.
- Amneal Pharmaceuticals, Inc.
- Wellona Pharma
- Pfizer, Inc.
- Novartis AG
The dystonia drugs market is poised for significant growth, with drug treatments considered the best option for dystonia due to their ability to provide quick and complete relief from the condition.
Key Takeaways:
- This report provides insights into geographical regions and subsegments with rapid growth and significant market share.
- It examines the factors driving and limiting market growth, offering insights into potential pitfalls and opportunities.
- The report profiles leading market vendors and their positions in the market.
- It covers ongoing market developments and innovations in the dystonia drugs market.
For more information about this report visit https://www.researchandmarkets.com/r/jidfwp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900